Skip to content
10-K/A

Annual Report

TherapeuticsMD, Inc. TXMD

0001213900-26-037918

← back to feed
Filed
Apr 1, 2026 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Mar 30, 2026 11.57M sh
Shares Diluted FY 2025 · Dec 31, 2025 11.57M sh
Shares Diluted restated FY 2025 · Dec 31, 2024 11.53M sh
Stockholders Equity FY 2025 · Dec 31, 2025 $26.88M
Stockholders Equity FY 2025 · Dec 31, 2024 $27.37M
Stockholders Equity FY 2025 · Dec 31, 2023 $29.29M
Current Liabilities FY 2025 · Dec 31, 2025 $4.79M
Current Liabilities FY 2025 · Dec 31, 2024 $5.17M
Total Liabilities FY 2025 · Dec 31, 2025 $10.78M
Total Liabilities FY 2025 · Dec 31, 2024 $11.45M
Current Assets FY 2025 · Dec 31, 2025 $14.45M
Current Assets FY 2025 · Dec 31, 2024 $12.26M
Total Assets FY 2025 · Dec 31, 2025 $37.66M
Total Assets FY 2025 · Dec 31, 2024 $38.82M
Eps Diluted FY 2025 · Dec 31, 2025 −$0.05
Eps Diluted FY 2025 · Dec 31, 2024 −$0.19
Eps Basic FY 2025 · Dec 31, 2025 −$0.05
Eps Basic FY 2025 · Dec 31, 2024 −$0.19
Net Income FY 2025 · Dec 31, 2025 −$569K
Net Income FY 2025 · Dec 31, 2024 −$2.18M
Operating Income FY 2025 · Dec 31, 2025 −$4.39M
Operating Income restated FY 2025 · Dec 31, 2024 −$6.11M